期刊
MATERIALS
卷 14, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/ma14113083
关键词
biomarkers; nanoparticles; pancreatic cancer; targeted therapy
类别
资金
- Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania [1032/26/13.01.2021]
- Romanian National Authority for Scientific Research and Innovation, CNCS-UEFISCDI [PN-III-P2-2.1-PED-2019-0844, PN-III-P2-2.1-PED-2019-0997, PNIII-P2-2.1-PED-2019-3373]
Pancreatic cancer poses great challenges in treatment, but nanotechnology may offer hope for improving survival rates. Targeted delivery with biomarkers can reduce drug toxicity and enhance efficacy.
As the increase in therapeutic and imaging technologies is swiftly improving survival chances for cancer patients, pancreatic cancer (PC) still has a grim prognosis and a rising incidence. Practically everything distinguishing for this type of malignancy makes it challenging to treat: no approved method for early detection, extended asymptomatic state, limited treatment options, poor chemotherapy response and dense tumor stroma that impedes drug delivery. We provide a narrative review of our main findings in the field of nanoparticle directed treatment for PC, with a focus on biomarker targeted delivery. By reducing drug toxicity, increasing their tumor accumulation, ability to modulate tumor microenvironment and even improve imaging contrast, it seems that nanotechnology may one day give hope for better outcome in pancreatic cancer. Further conjugating nanoparticles with biomarkers that are overexpressed amplifies the benefits mentioned, with potential increase in survival and treatment response.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据